Cambridge Cognition (LON:COG) had its target price lowered by FinnCap from GBX 180 ($2.44) to GBX 155 ($2.10) in a report released on Wednesday. The firm currently has a corporate rating on the stock.
Cambridge Cognition (COG) traded up GBX 8.50 ($0.12) during trading hours on Wednesday, reaching GBX 129.50 ($1.76). The company had a trading volume of 70,053 shares, compared to its average volume of 8,362. Cambridge Cognition has a 12-month low of GBX 68.20 ($0.92) and a 12-month high of GBX 169 ($2.29).
COPYRIGHT VIOLATION WARNING: “Cambridge Cognition (COG) PT Lowered to GBX 155 at FinnCap” was first posted by Markets Daily and is the property of of Markets Daily. If you are accessing this piece of content on another domain, it was stolen and reposted in violation of United States and international trademark & copyright law. The legal version of this piece of content can be read at https://www.themarketsdaily.com/2018/01/14/cambridge-cognition-cog-pt-lowered-to-gbx-155-at-finncap.html.
Cambridge Cognition Holdings plc and its subsidiaries develop and commercialize computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company’s segments include Pharmaceutical Clinical Trials, Academic Research and Healthcare Technology. The Pharmaceutical Clinical Trials segment includes products and services for use in regulated pharmaceutical clinical trials.
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.